Drug Shortage Report for JALYN
| Report ID | 149987 |
| Drug Identification Number | 02372010 |
| Brand name | JALYN |
| Common or Proper name | dutasteride/tamsulosin hydrochloride modified release capsules |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TAMSULOSIN HYDROCHLORIDE DUTASTERIDE |
| Strength(s) | 0.4MG 0.5MG |
| Dosage form(s) | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 30s |
| ATC code | G04CA |
| ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-11-25 |
| Estimated end date | 2022-03-02 |
| Actual end date | 2022-03-01 |
| Shortage status | Resolved |
| Updated date | 2022-03-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-03-02 | French | Compare |
| v5 | 2022-03-02 | English | Compare |
| v4 | 2022-02-16 | French | Compare |
| v3 | 2022-02-16 | English | Compare |
| v2 | 2021-11-26 | French | Compare |
| v1 | 2021-11-26 | English | Compare |
Showing 1 to 6 of 6